Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Claud B who wrote (6742)	5/12/1999 6:32:00 PM
From: VLAD	of 7041

Claud, Face it. You are in DEEP DOO DOO with your ZONA. Day trading and short covering has given ZONA a nice pop from 8 3/4 to 15 1/4 over the last 3 trading days. But mark my words, when the volume tames down starting tomorrow nobody will support this stock because it ain't worth much more than book value with current fundamentals. VLAD PS I got a good laugh studying the history of this company. The initial hype over a sterilization vaccine was such a crock of s### that I couldn't stop laughing. Even if such a vaccine were perfected it wouldn't stop female dogs from going into heat and spotting on the pet owners floor etc. Nor would it change the high incidence of mammary adenocarcinomas or pyometrias that can only be truely preventing via early spaying. I don't know what kind of "scientist" could even think that such a vacine would be a block buster product. Even a first year veterinary student could tell you what I just explained. I also was apauled by the 2 articles I read from the Houston Chronicle--it certainly gives Bill Wexler's claims a lot of credibility. IMHO the Vasoscam story is no better than the pet sterilization concept. It is hype and bad science--nothing more. The part that I really don't understand is that SGP ever involved itself with the product. I think that they made some assumptions about Vasoscam that didn't pan out--starting that efficacy wasn't that important so long as they had an oral ED pill to represent in the market. The FDA may have allowed Pfizer to get away with murder on Viagra but evidently they won't budge on neither efficacy nor safety issues concerning Vasomax. SGP made a HUGE mistake on Vasomax but the money invested thus far is peanuts on a relative scale for a big pharmaceutical company.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next